Introduction {#sec1}
============

Gastroenteritis is the most common manifestation of human *Salmonella* infections, especially the infection caused by *Salmonella* Typhimurium and *Salmonella* Enteritidis serotypes. Epidemiological studies in different countries have shown an increase in *Salmonella* Enteritidis infections during recent years. According to the WHO, since 1990, *Salmonella* Enteritidis has been considered the most common cause of gastroenteritis worldwide [@bib1], whereas previously, *Salmonella* Typhimurium had been the main cause of *Salmonella* gastroenteritis [@bib2].

In most cases, *Salmonella* gastroenteritis is self-limiting and usually heals without the need for antibiotic therapy [@bib1], but it may progress to systemic diseases such as bacteraemia [@bib3], meningitis [@bib4] and endocarditis [@bib5], especially in patients with an immunodeficiency [@bib6] or neoplastic disease that are taking antibiotics and immune suppressor drugs. Pregnant women and the elderly are more sensitive to *Salmonella* infections. For effective epidemiological surveillance and control of *Salmonella* species, we need accurate subtyping information of strains to identify potential sources of infection. Many traditional ways of typing, such as biochemical and serological characterizations, are tedious and expensive with limited epidemiological value. Moreover, these methods do not have an adequate discriminatory capacity for strains with identical serotype or biochemical characteristics [@bib7]. Different molecular methods have been used by researchers for genotyping enteric bacteria, among which Enterobacterial Repetitive Intergenic Consensus (ERIC) -PCR is a powerful method for DNA fingerprinting. In this method, repeated oligonucleotides are used as a starter of DNA synthesis when there is no need for information on the target DNA sequence, which makes it a powerful method with general applications. This method is faster, simpler and more economical than other genomic typing methods [@bib8].

In recent years, *Salmonella* Enteritidis has become a major public health problem, and the main cause of both human and animal salmonellosis in many countries. To analyse this problem, the objectives of this study were to determine the extent of genetic variation and clonality among food and clinical strains of *Salmonella* Enteritidis by examination of susceptibility to common antibiotics, plasmid analysis and ERIC-PCR patterns. In addition, we investigate the prevalence of *Salmonella* Enteritidis in children's stool samples.

Materials and methods {#sec2}
=====================

Bacterial isolates {#sec2.1}
------------------

A total of 30 *Salmonella* Enteritidis isolates, including 15 isolates from humans and 15 from food, were used during this study. The human isolates were collected from 1950 patients with diarrhoea admitted to the Children's Medical Centre Hospital in Tehran, from April to November 2014. All human isolates were recovered from stool of patients suffering from diarrhoea, except for one isolate which was obtained from the blood of a diarrheal patient. This patient was admitted to the hospital with acute gastroenteritis and *Salmonella* serogroup D was obtained from blood after 3 weeks of initial isolation from stool. Diarrhoeal cases were defined as patients with more than three non-bloody episodes of diarrhoea per day. The food isolates were taken from different food sources, including chicken, lamb, beef and duck meats were obtained from the Microbiology Department of the Veterinary Faculty, Tehran University during the same period of time. Standard microbiological methods were used for identification of *Salmonella* isolates [@bib9]. The serogroup characterization of isolates was performed via slide-agglutination test with polyvalent and monospecific antisera against somatic and flagella antigens in Phase I and II according to the manufacturer's instructions (Difco, Franklin Lakes, NJ, USA). The identity of *Salmonella* Enteritidis isolates was confirmed by a multiplex-PCR as described previously [@bib10].

Antimicrobial susceptibility testing {#sec2.2}
------------------------------------

The disk-diffusion method was used to determine the susceptibility of strains as instructed by the CLSI guidelines [@bib11]. The antimicrobial agents were as follows: amoxicillin (20 μg), gentamicin (10 μg), chloramphenicol (30 μg), cotrimoxazole (25 μg), nalidixic acid (30 μg), ciprofloxacin (5 μg), cefotaxime (30 μg), ceftazidime (30 μg), ceftriaxone (30 μg), cephalexin (30 μg), streptomycin (10 μg), tetracycline (30 μg), imipenem (10 μg), meropenem (10 μg), nitrofurantoin (30 μg), colistin sulphate (25 μg) (Mast Diagnostics, Mast Group Ltd, Merseyside, UK). The strain organism used for quality control was *Escherichia coli* ATCC 25922.

Plasmid profiling {#sec2.3}
-----------------

Plasmids were extracted using a Qiagen Mini Plasmid Kit (Qiagen Mississauga, Ont, Canada). A 0.8% agarose gel was used for plasmid horizontal electrophoresis; moreover, standard *E. coli* AC11 strain with 68 kb, 7.2 kb and 1.9 kb plasmids was used as the control. The molecular weight of plasmids was determined by [Seqaid]{.smallcaps} П software (version 3.5, Kansas State University, Manhattan, KS, USA).

ERIC-PCR and (GTG)~5~ amplification {#sec2.4}
-----------------------------------

One colony of each bacterial strain was purified using a commercial kit (Bioneer, Seoul, Korea) and used as DNA template. Primer pairs for ERIC-PCR amplification were as follows: ERIC-1R (5\'-ATGTAAGCTCCTGGGGATTCAC-3\') and ERIC-2 (5\'-AAGTAAGTGACTGGGGTGAGCG-3\') .The (GTG)~5~ amplification was performed using primers described previously [@bib12]. Amplification was performed in a reaction mixture containing hot start Taqplus Master Mix 12.5 μL, 20 pmol of each primer, 3 μL of DNA, 2.5 μL of PCR buffer and 5 μL ultra-pure water (final volume 25 μL). ERIC-PCR amplification was performed using a programme comprising one denaturation step at 95°C for 5 min; four cycles of 94°C for 4 min, 53°C for 4 min, 72°C for 4 min; 30 cycles of 94°C for 30 s, 53°C for 1 min, 72°C for 1 min; and one cycle at 72°C for 7 min.

The (GTG)~5~ amplification included one denaturation step at 95°C for 5 min; four cycles of 94°C for 4 min, 50°C for 4 min, 72°C for 4 min; 29 cycles of 94°C for 30 s, 50°C for 1 min, 72°C for 1 min; and one cycle at 72°C for 7 min. Gel images were analysed using [Gel compar]{.smallcaps} II version 4.0 (Applied Maths, Sint-Martens-Latem, Belgium). The dendrogram was generated according to the unweighted pair group method with arithmetic (UPGMA) ([Fig. 1](#fig1){ref-type="fig"}).

Results {#sec3}
=======

In general, 26 different *Salmonella* serovars were recovered from children (14 boys and 12 girls). The distribution of *Salmonella* serovars in stool samples was 14 (54%) serogroup D, 6 (23%) *Salmonella paratyphi* C, 2 (8%) *S. paratyphi* B, 3 (11%) *Salmonella arizonae* and 1 (4%) *S. paratyphi* A, respectively. All isolates belonging to serogroup D were identified as *Salmonella* Enteritidis by Multiplex PCR.

Antibiotic resistance {#sec3.1}
---------------------

In the evaluation of 16 antibiotics, seven antibiotic-resistance patterns were observed among clinical and food isolates. The most common anti-biotype was AB1 (43.2%), which was indicative of resistance to nitrofurantoin. The second anti-biotype was AB2 (40.5%) which characterized a nitrofurantoin-nalidixic acid resistance phenotype. We did not observe any resistance to cephalexin, ceftriaxone, ceftazidime and cefotaxime, ciprofloxacin, imipenem or meropenem, chloramphenicol and gentamicin ([Table 1](#tbl1){ref-type="table"}).

Plasmid profiles {#sec3.2}
----------------

Plasmid profiling of 30 *Salmonella* Enteritidis isolates revealed seven different profiles (P1--P7) with one to three bands ranging from 1500 bp to 68 000 bp. Two plasmid profiles (P2 and P7) were common among clinical and food isolates; in addition, 7 (47%) clinical isolates and 12 (80%) food isolates were P7. A large plasmid (68 kb) was common in all profiles. The second most common pattern was P2 (16.7 %), which included two other plasmids (1.96 kb and 2.6 kb) as well as 68 kb ([Table 2](#tbl2){ref-type="table"}).

ERIC-PCR {#sec3.3}
--------

Genotyping of the 30 isolates showed five different banding patterns, with two major common types (CT1 and CT2) comprising 76.6% of total isolates, each of which consisted of both clinical and food isolates. The CT3 with two members only included clinical isolates with the single blood isolate in this category. Four isolates in CT4 were all taken from food samples. One single type (ST1) was also detected, which corresponded to a food isolate. The isolates of duck meat origin were exclusively different from the rest of the samples with single type (ST). In addition, this strain was isolated from north of Iran and both (GTG)~5~ and ERIC-PCR successfully separated the strain as a single type ([Fig. 2](#fig2){ref-type="fig"}; dendrogram 1).

(GTG)~5~-PCR genotyping {#sec3.4}
-----------------------

This method grouped 21 isolates of different origins (70%) in a single cluster (CT2); two other common types (CT1 and CT3) and one single type were also detected. This genotyping method showed more genetic similarity between human, and food isolates ([Fig. 2](#fig2){ref-type="fig"}; dendrogram 2).

Discrimination index {#sec3.5}
--------------------

The discriminatory power of ERIC-PCR and (GTG)~5~-PCR was assessed by Simpson's diversity index, as presented by Hunter and Gaston [@bib13].

Discussion {#sec4}
==========

*Salmonella* species have been defined as major food-borne pathogens in humans worldwide. The predominant serotypes have changed over time and are now various in different geographic locations [@bib14]. In this study, the prevalence of *Salmonella* Enteritidis was 54%, which showed the dominance of this serovar in Iran. Recent reports from Brazil, Poland, Malaysia, China and Greece have shown the same serovar as the dominant serovar with the frequencies ranging from 34% to 86%, which reveals a coincident rise of this serovar around the world [@bib15], [@bib16], [@bib17], [@bib18], [@bib19].

In our study, all isolates were susceptible to cephalexin, ceftriaxone, ceftazidime, cefotaxime and ciprofloxacin. These results indicate that cephalosporins as well as fluoroquinolones are still appropriate drugs that can be used against invasive and systemic infection caused by *Salmonella.* Furthermore, all isolates were susceptible to monobactams (imipenem or meropenem), which shows that they can be considered as alternative drugs for clinical cases where more resistance to extended-spectrum antimicrobials is encountered. This result is due to limited prescription of carbapenems in Iran. However, their toxic and more harmful nature against microflora should not be ignored. A previous report from Iran showed 100% sensitivity to amikacin, ceftriaxone, xanofloxacin, levofloxacin, norfloxacain and imipenem [@bib20]. In our study, the most frequently antibiotic resistance was observed in nitrofurantoin (100%) and nalidixic acid (73%) among isolates of human origin. The isolates of food origin also showed their highest level of resistance to nitrofurantoin (86.7%) and nalidixic acid (13.3%), but they were significantly different (p \<0.005) from clinical isolates. The observed level of resistance to these two agents among human and food isolates was higher than that reported by previous studies in Iran [@bib21]. The data obtained in the present study indicated 73% resistance to this antimicrobial agent. The increased resistance to nalidixic acid among *Salmonella* Enteritidis isolates was also previously reported in other countries, including some in Europe [@bib22]. This increase might be due to point mutations in DNA gyrase genes (*gyrA*) or to activation of efflux pumps among this bacterial genus [@bib23]. Morshed and Peighambari showed that 77% of clinical isolates and 24% of food isolates were resistant to nalidixic acid, which is consistent with our results, which showed 73% resistance among clinical isolates and 13.3% among food isolates [@bib20]. Among clinical isolates, 73.3% were multiple drug resistance phenotypes and were resistant to at least three or more antibiotic families, while among food isolates, only 20% had multiple resistance patterns. Generally, in this study, antibiotic resistance rate was much higher than in food isolates. It seems that improper and indiscriminate use of antibacterial drugs in both human and veterinary medicine without careful evaluation of bacterial sensitivity, has led to a widespread resistance to antimicrobial drugs [@bib24]. Horizontal transfer and clonal spread of resistance genes may occur among food-producing animals and humans [@bib25].

Plasmid profiling has been used successfully for the typing of *Salmonella* Enteritidis strains, but it has some limitations. Many *Salmonella* Enteritidis strains carry serotype-specific virulence plasmid with different sizes (50--100 kb) [@bib26]. In our study, all isolates successfully typed by plasmid profiling, and one single large plasmid (68 kb) was common in all the profiles, which can be proposed as a serotype-specific virulence plasmid. Morshed and Peighambari have reported six plasmid profiles (A--F) between 49 *Salmonella* Enteritidis isolates of human and animal origin in Iran. In their study, 98% of isolates had the 68-kb plasmid and 2% had no plasmid [@bib20]. Liebana *et al.* also reported a single 57-kb plasmid among 56% of their *Salmonella* Enteritidis isolated from the UK. He showed that the discriminatory power of this method was more than pulsed-field gel electrophoresis (PFGE) and less than ribotyping [@bib27]. Extrachromosomal DNA was considered as an unstable genetic marker. Consequently, strains that show identical chromosomal features may have different plasmid patterns [@bib28]. In addition, the same plasmid patterns can be observed among isolates with different chromosomal characteristics [@bib29].

ERIC-PCR is a powerful DNA-based typing method for fingerprinting. ERIC-PCR analysis is useful for studying the epidemiology of *Salmonella* Enteritidis [@bib12]. Using ERIC primers, between 30 strains of *Salmonella* Enteritidis isolates four main clusters had 60% similarity. The majority of isolates (23; 76%) fell in a major cluster (A) with two common types (95% similarity), while the remaining seven strains were classified into two distinct clusters with one single type. Both clinical and food isolates existed in the clusters, which showed different plasmid profiles and antimicrobial resistance properties. The most common type was CT2 (40%), which contained six human isolates and six food isolates, respectively. In this type, food isolates had P7 plasmid patterns and resistance phenotypes (AB1), but the human isolates had different plasmid patterns and resistance phenotypes. This indicates that human isolates had more diverse types. The CT3 had two clinical members with identical resistance phenotypes (AB2) and plasmid patterns (P5); however, they had different origins (stool and blood). The two isolates belonged to one patient, but were obtained on two occasions. The result shows the importance of the treatment and control of *Salmonella* infections in high-risk individuals, especially for children, which can lead to systematic infections.

Food isolates of duck meat origin were exclusively different from the rest of the samples with single type (ST). This strain was isolated from the north of Iran and both (GTG)~5~ and ERIC-PCR successfully separated the strain as a single type. The (GTG)~5~ analysis indicated CT2 as the most common type (70%) with 21 clinical and food isolates falling in this group. The diversity index of population was obtained to be 0.48 and 0.70 by (GTG)~5~ and ERIC-PCR analysis, respectively, which indicates the higher discriminatory power of the ERIC-PCR method. Using ERIC-PCR, Suh and Song showed a high genetic homogeneity among 22 *Salmonella* Enteritidis isolates of human and chicken origin in South Korea between 2001 and 2002 [@bib12]. Furthermore, several investigators have shown good discriminatory power and typing capacity of ERIC-PCR for *Salmonella* Enteritidis isolates from human and food origin [@bib30], [@bib31]. In the study of Campioni *et al.* performed with 128 *Salmonella* Enteritidis isolates of human and food origin over a 24-year period in Brazil, ERIC-PCR and PFGE exhibited a high genetic similarity, PFGE being considered the reference standard method for the typing of *Salmonella* Enteritidis strains [@bib32]. Ammari *et al.* have shown that ERIC-PCR exhibited a higher discriminatory power than PFGE [@bib33].

In conclusion, *Salmonella* Enteritidis was phenotypically and genotypically homogeneous and was clonally dispersed among food and human populations in our study. These clones may continue to exist over a considerable period of time in Tehran and spread in different time occasions. This supports the notion that infected animals and humans are important sources of contamination in the environment and the food chain. Using combined genotyping techniques and greater number of isolates makes it more possible to trace the origin of infections in epidemiological investigations.
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![DNA fingerprint patterns of *Salmonella* Enteritidis strains from human and food sources by ERIC-PCR. Lane 1: M1 (SM041) 100 bp DNA Ladder; Lane 10: M2 (SM0321) 100 bp DNA Ladder Plus; Lanes 2--9: clinical and food samples.](gr1){#fig1}
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###### 

The antibiotic resistance pattern of clinical and food isolates

Table 1

  Resistance pattern   Antibiotics   \% resistance                                                           
  -------------------- ------------- --------------- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -------
  AB ~1~               S             S               S   R   S   S   S   S   S   S   S   S   S   S   S   S   43.2%
  AB ~2~               S             S               S   R   S   S   S   S   S   S   S   S   S   R   S   S   40.5%
  AB ~3~               S             R               R   R   R   S   S   S   S   S   S   S   S   R   S   S   3.3%
  AB ~4~               S             S               R   R   R   R   S   S   S   S   S   S   S   R   S   S   3.3%
  AB ~5~               S             S               R   R   S   R   S   S   S   S   S   S   S   S   S   S   3.3%
  AB ~6~               S             S               S   S   S   R   S   S   S   S   S   S   S   S   S   S   3.3%
  AB ~7~               S             S               S   R   S   R   S   S   S   S   S   S   S   S   S   S   3.3%

Abbreviations for antibiotics are as follows: CTX, cefotaxime; A, amoxicillin; T, tetracycline; IN, nitrofurantoin; TS trimethoprim-sulfamethoxazole; S, streptomycin; C, chloramphenicol; CRO, ceftriaxone; GM, gentamicin; Co, colistin sulphate; CAZ, ceftazidime; CIP, ciprofloxacin; CFX, cephalexin; NA, nalidixic acid; MEM, meropenem; IMI, imipenem.

###### 

Plasmid profiles and antibiotic resistance pattern of *Salmonella* Enteritidis isolated from human and food origin

Table 2

  Plasmid profile   Plasmid content     Resistance profile
  ----------------- ------------------- ---------------------------------------------------
  P1                68000- 6300- 4900   AB2 (IN-NA)
  P2                68000- 2600- 1960   AB1 (IN), AB3 (A-T-IN-TS-NA), AB2 (IN-NA)
  P3                68000-2600- 2150    AB4 (T-IN-TS-S-NA)
  P4                68000- 1500- 2150   AB5 (T-IN-S)
  P5                68000- 3300         AB2 (IN-NA)
  P6                68000- 2900         AB1 (IN)
  P7                68000               AB1, AB2, AB3 (A-T-IN-TS-NA), AB6 (S), AB7 (IN-S)

Abbreviations for antibiotics are as follows: A, amoxicillin; T, tetracycline; IN, nitrofurantoin; TS trimethoprim-sulfamethoxazole; S, streptomycin; NA, nalidixic acid.
